Results 221 to 230 of about 397,302 (354)

Real-time observation of DNA looping dynamics of Type IIE restriction enzymes NaeI and NarI [PDF]

, 2006
Bram van den Broek, Francesco Vanzi, Davide Normanno, Francesco S. Pavone, Gijs J. L. Wuite   +4 more
openalex   +1 more source

SNUPN‐Related Muscular Dystrophy: Novel Phenotypic, Pathological and Functional Protein Insights

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective SNUPN‐related muscular dystrophy or LGMDR29 is a new entity that covers from a congenital or childhood onset pure muscular dystrophy to more complex phenotypes combining neurodevelopmental features, cataracts, or spinocerebellar ataxia. So far, 12 different variants have been described.
Nuria Muelas, Pablo Iruzubieta, Alberto Damborenea, Laura Pérez‐Fernández, Inmaculada Azorín, Juan Carlos Jiménez García, Ana Töpf, Pilar Martí, Lorena Fores‐Toribio, María Manterola, Rosana Blanco‐Mañez, Oihane Pikatza‐Menoio, Sonia Alonso‐Martín, Volker Straub, Aitziber L. Cortajarena, Adolfo López de Munain, David De Sancho, Lorea Blázquez, Juan J. Vilchez   +18 more
wiley   +1 more source

Comparing the precision of two digital PCR applications for copy number comparisons in protists. [PDF]

Sci Rep
Gross M, Stoeck T, Mauvisseau Q, Schrøder-Nielsen A, Dunthorn M.   +4 more
europepmc   +1 more source

DNA sequencing analysis of several G6PD variants previously defined by PCR-restriction enzyme analysis [PDF]

, 2006
Gerardo Vaca, Eliakym Arámbula‐Meraz
openalex   +1 more source

CSF Levels of NPTX2 Are Associated With Less Brain Atrophy Over Time in Cognitively Unimpaired Individuals

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Neuronal pentraxin 2 (NPTX2) is a synaptic protein involved in synaptic plasticity and regulation of neuronal excitability. Lower baseline cerebrospinal fluid (CSF) NPTX2 levels have been shown to be associated with an earlier onset of mild cognitive impairment (MCI), a pre‐dementia syndrome, even after CSF Alzheimer's Disease (AD)
Juan P. Vazquez, Corinne Pettigrew, Yuxin Zhu, Claire Anderson, Guray Erus, Christos Davatzikos, Michael Miller, Abhay Moghekar, Sungtaek Oh, Chan‐Hyun Na, Marilyn Albert, Paul Worley, Anja Soldan   +12 more
wiley   +1 more source

Advances in Diversity, Evolutionary Dynamics and Biotechnological Potential of Restriction-Modification Systems. [PDF]

Microorganisms
Chen C, Zhang Y, Wu H, Qiao J, Caiyin Q.
europepmc   +1 more source

Impact of APOE ε4 Genotype Load on Cognitive Function and Lipid Metabolism in Patients With Cerebral Small Vessel Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Apolipoprotein ε4 (APOE ε4) is a potent genetic risk factor for Alzheimer's disease (AD). However, its role in cerebral small vessel disease (CSVD) remains unclear. Given the clinical and pathological similarities between CSVD and AD, this study aimed to investigate the associations of APOE ε4 gene dosage with cognitive function and
Tingru Jin, Haocheng Yang, Feng Liu, Sihao Lin, Junru Hu, Jian Wang, Yulan Gou   +6 more
wiley   +1 more source

Anti-plasmid defense in hypervirulent <i>Klebsiella pneumoniae</i> involves Type I-like and Type IV restriction modification systems. [PDF]

Emerg Microbes Infect
Oo G, Low WW, Yong M, Stanton TD, Ayuni NN, Bifani P, Wyres KL, Gan YH.   +7 more
europepmc   +1 more source

DNA Sequence Modulates the Conformation of the Food Mutagen 2-Amino-3-methylimidazo[4,5-f]quinoline in the Recognition Sequence of the NarI Restriction Enzyme^, [PDF]

, 2007
Feng Wang, C. Eric Elmquist, James S. Stover, Carmelo J. Rizzo, Michael P. Stone   +4 more
openalex   +1 more source

BlihIA-A Novel Type I Restriction-Modification System from <i>Bacillus licheniformis</i> Is Sensitive to In Vitro Inhibition by ArdB Antirestriction Protein. [PDF]

Int J Mol Sci
Kudryavtseva A, Berezov R, Utkina A, Kotovskaya O, Skutel M, Trofimova A, Isaev A, Manukhov I.   +7 more
europepmc   +1 more source